|
|
Volumn 8, Issue 3, 2008, Pages 193-204
|
|
DNA repair pathways as targets for cancer therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE;
5 AZA 2' DEOXYCYTIDINE;
6 O BENZYLGUANINE;
7 HYDROXYSTAUROSPORINE;
ABT 888;
AG 014699;
ALKANESULFONIC ACID;
ANTIINFECTIVE AGENT;
APHIDICOLIN;
AZ 2281;
AZD 2281;
BLEOMYCIN;
BSI 201;
CAMPTOTHECIN;
CARBOPLATIN;
CHLORMETHINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DNA;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLIC ACID DERIVATIVE;
GEMCITABINE;
GPI 21016;
HYDROXYUREA;
INO 1001;
IRINOTECAN;
LOMEGUATRIB;
MERCAPTOPURINE;
MITOMYCIN C;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
NU 7441;
TEMOZOLOMIDE;
TOPOTECAN;
TRC 102;
UNCLASSIFIED DRUG;
WORTMANNIN;
XL 844;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
CANCER THERAPY;
CELL CYCLE;
CELL SURVIVAL;
CLINICAL TRIAL;
DNA DAMAGE;
DNA REPAIR;
DNA REPLICATION;
DNA SYNTHESIS INHIBITION;
DRUG EFFICACY;
GLIOMA;
HEMATOLOGIC MALIGNANCY;
HUMAN;
LUNG NON SMALL CELL CANCER;
NONHUMAN;
OVARY CANCER;
PRESCRIPTION;
PRIORITY JOURNAL;
REVIEW;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL SURVIVAL;
DNA DAMAGE;
DNA REPAIR;
DNA REPAIR ENZYMES;
HUMANS;
MEDICAL ONCOLOGY;
MODELS, BIOLOGICAL;
NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 39749166975
PISSN: 1474175X
EISSN: 14741768
Source Type: Journal
DOI: 10.1038/nrc2342 Document Type: Review |
|
Times cited : (1356)
|
|
References (135)
|
